Health policy model: long-term predictive results associated with the management of hepatitis C virus-induced diseases in Italy

by Mennini FS, Marcellusi A, Andreoni M, Gasbarrini A, Salomone S, Craxì A
Published 2014-06-01

Population-based cohort study on comparative effectiveness and safety of biologics in inflammatory bowel disease

by Di Domenicantonio R, Trotta F, Cascini S, Agabiti N, Kohn A, Gasbarrini A, Davoli M, Addis A
Published 2018-02-01

Overt hepatic encephalopathy in Italy: clinical outcomes and healthcare costs

by Roggeri DP, Roggeri A, Rossi E, Cinconze E, Gasbarrini A, Monici Preti P, De Rosa M
Published 2015-07-01

Modulation of the gut microbiota composition by rifaximin in non-constipated irritable bowel syndrome patients: a molecular approach

by Soldi S, Vasileiadis S, Uggeri F, Campanale M, Morelli L, Fogli MV, Calanni F, Grimaldi M, Gasbarrini A
Published 2015-12-01